Universal precautions: attitudes of Australian and New Zealand anaesthetists

Med J Aust. 1997 Feb 3;166(3):138-40.

Abstract

Objective: To survey the attitudes of a group of Australasian anaesthetists to the risks of bloodborne infections, and their understanding of Universal Precautions.

Design: A questionnaire survey.

Setting: A conference on health risks to anaesthetists in August 1995.

Participants: 162 Australian and New Zealand anaesthetists.

Results: Two-thirds of anaesthetists favoured preoperative HIV and hepatitis B and C testing; they rarely took "risk" histories from patients preoperatively. Only 37% always wore gloves while administering anaesthetics, and 67% reported they resheathed needles. Thirty-nine per cent had had needlestick injuries in the preceding 12 months; 43% did not always report them. The perceived needlestick accident rate was 1 in 1300 anaesthetics. Most (90%) were immunised against hepatitis B, but 20% of these had never had their serological response checked. Twelve per cent of anaesthetists had had occupational exposure to HIV. A high proportion of the anaesthetists understood the principles of Universal Precautions, but only half of them believed these to be practical.

Conclusions: The current situation of Australasian anaesthetists not complying with Universal Precautions and not taking a risk history for bloodborne pathogens may carry the greatest risk of accidental infection.

MeSH terms

  • Acquired Immunodeficiency Syndrome / diagnosis
  • Acquired Immunodeficiency Syndrome / prevention & control*
  • Anesthesiology*
  • Attitude of Health Personnel*
  • Australia
  • Hepatitis B / diagnosis
  • Hepatitis B / prevention & control*
  • Hepatitis B Vaccines / administration & dosage
  • Hepatitis C / diagnosis
  • Hepatitis C / prevention & control*
  • Humans
  • Mass Screening
  • Needlestick Injuries / prevention & control
  • New Zealand
  • Occupational Diseases / prevention & control*
  • Population Surveillance
  • Protective Devices / statistics & numerical data
  • Risk Assessment
  • Serologic Tests
  • Surveys and Questionnaires
  • Universal Precautions / statistics & numerical data*

Substances

  • Hepatitis B Vaccines